# A Study of LY4268989 (MORF 057) in Healthy Participants

> **NCT07707375** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 50 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY4268989

## Key facts

- **NCT ID:** NCT07707375
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07707375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07707375, "A Study of LY4268989 (MORF 057) in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07707375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*